Copper nanowire embedded hypromellose: An antibacterial nanocomposite film.
Antimicrobial
Biocompatibility
Copper nanowire
Hypromellose film
Journal
Journal of colloid and interface science
ISSN: 1095-7103
Titre abrégé: J Colloid Interface Sci
Pays: United States
ID NLM: 0043125
Informations de publication
Date de publication:
15 Feb 2022
15 Feb 2022
Historique:
received:
11
07
2021
revised:
18
08
2021
accepted:
21
09
2021
pubmed:
9
10
2021
medline:
15
12
2021
entrez:
8
10
2021
Statut:
ppublish
Résumé
The present work reports a novel antibacterial nanocomposite film comprising of copper nanowire impregnated biocompatible hypromellose using polyethylene glycol as a plasticiser. Detailed physico-chemical characterization using X-ray diffraction, Fourier transform infrared spectroscopy, UV-Visible spectroscopy and electron microscopy shows uniform dispersion of copper nanowire in the polymer matrix without any apparent oxidation. The film is flexible and shows excellent antibacterial activity against both Gram positive and negative bacteria at 4.8 wt% nanowire loading with MIC values of 400 µg/mL and 500 µg/mL for E. coli and S. aureus respectively. Investigation into the antibacterial mechanism of the nanocomposite indicates multiple pathways including cellular membrane damage caused by released copper ions and reactive oxygen species generation in the microbial cell. Interestingly, the film showed good biocompatibility towards normal human dermal fibroblast at minimum bactericidal concentration (MBC). Compared to the copper nanoparticles reported earlier in vitro studies, this low cytotoxicity of copper nanowires is due to the slow dissolution rate of the film and production of lower amount of ROS producing Cu
Identifiants
pubmed: 34624763
pii: S0021-9797(21)01589-7
doi: 10.1016/j.jcis.2021.09.130
pmc: PMC7611964
mid: EMS135989
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Hypromellose Derivatives
3NXW29V3WO
Copper
789U1901C5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
30-39Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203145
Pays : United Kingdom
Organisme : European Research Council
ID : 714712
Pays : International
Informations de copyright
Copyright © 2021. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.